nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP1A2—chronic obstructive pulmonary disease	0.367	1	CbGaD
Delavirdine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.039	0.0921	CbGbCtD
Delavirdine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.039	0.0921	CbGbCtD
Delavirdine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0352	0.0832	CbGbCtD
Delavirdine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0324	0.0765	CbGbCtD
Delavirdine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0324	0.0765	CbGbCtD
Delavirdine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0306	0.0722	CbGbCtD
Delavirdine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0296	0.07	CbGbCtD
Delavirdine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0296	0.07	CbGbCtD
Delavirdine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0264	0.0624	CbGbCtD
Delavirdine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0249	0.0587	CbGbCtD
Delavirdine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0246	0.058	CbGbCtD
Delavirdine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0168	0.0397	CbGbCtD
Delavirdine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0164	0.0387	CbGbCtD
Delavirdine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.016	0.0378	CbGbCtD
Delavirdine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0143	0.0337	CbGbCtD
Delavirdine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00838	0.0198	CbGbCtD
Delavirdine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00792	0.0187	CbGbCtD
Delavirdine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00099	CcSEcCtD
Delavirdine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.000989	CcSEcCtD
Delavirdine—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000988	CcSEcCtD
Delavirdine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00098	CcSEcCtD
Delavirdine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00098	CcSEcCtD
Delavirdine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.000979	CcSEcCtD
Delavirdine—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000977	CcSEcCtD
Delavirdine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000163	0.000973	CcSEcCtD
Delavirdine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.000973	CcSEcCtD
Delavirdine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000965	CcSEcCtD
Delavirdine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000965	CcSEcCtD
Delavirdine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000965	CcSEcCtD
Delavirdine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000161	0.000964	CcSEcCtD
Delavirdine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000962	CcSEcCtD
Delavirdine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000161	0.00096	CcSEcCtD
Delavirdine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000161	0.00096	CcSEcCtD
Delavirdine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.000956	CcSEcCtD
Delavirdine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00016	0.000956	CcSEcCtD
Delavirdine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.000953	CcSEcCtD
Delavirdine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000159	0.000953	CcSEcCtD
Delavirdine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.000952	CcSEcCtD
Delavirdine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000159	0.000952	CcSEcCtD
Delavirdine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.000952	CcSEcCtD
Delavirdine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000159	0.000948	CcSEcCtD
Delavirdine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000944	CcSEcCtD
Delavirdine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00094	CcSEcCtD
Delavirdine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000939	CcSEcCtD
Delavirdine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000932	CcSEcCtD
Delavirdine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000929	CcSEcCtD
Delavirdine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.000925	CcSEcCtD
Delavirdine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000919	CcSEcCtD
Delavirdine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000153	0.000916	CcSEcCtD
Delavirdine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.000916	CcSEcCtD
Delavirdine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000915	CcSEcCtD
Delavirdine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000152	0.000911	CcSEcCtD
Delavirdine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00091	CcSEcCtD
Delavirdine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.000909	CcSEcCtD
Delavirdine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000903	CcSEcCtD
Delavirdine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000899	CcSEcCtD
Delavirdine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00015	0.000894	CcSEcCtD
Delavirdine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000894	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.000893	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000149	0.000893	CcSEcCtD
Delavirdine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.000886	CcSEcCtD
Delavirdine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000148	0.000886	CcSEcCtD
Delavirdine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000882	CcSEcCtD
Delavirdine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.000881	CcSEcCtD
Delavirdine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000877	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000146	0.000874	CcSEcCtD
Delavirdine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.000874	CcSEcCtD
Delavirdine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000146	0.000874	CcSEcCtD
Delavirdine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.000871	CcSEcCtD
Delavirdine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000146	0.000871	CcSEcCtD
Delavirdine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000145	0.000868	CcSEcCtD
Delavirdine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000864	CcSEcCtD
Delavirdine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.000862	CcSEcCtD
Delavirdine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000144	0.000862	CcSEcCtD
Delavirdine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000144	0.000862	CcSEcCtD
Delavirdine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.000859	CcSEcCtD
Delavirdine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000854	CcSEcCtD
Delavirdine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000143	0.000853	CcSEcCtD
Delavirdine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000142	0.000851	CcSEcCtD
Delavirdine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000849	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.000846	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000141	0.000846	CcSEcCtD
Delavirdine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000141	0.000845	CcSEcCtD
Delavirdine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000141	0.000845	CcSEcCtD
Delavirdine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.000845	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000843	CcSEcCtD
Delavirdine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000838	CcSEcCtD
Delavirdine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000838	CcSEcCtD
Delavirdine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000838	CcSEcCtD
Delavirdine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000838	CcSEcCtD
Delavirdine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.000837	CcSEcCtD
Delavirdine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000835	CcSEcCtD
Delavirdine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000835	CcSEcCtD
Delavirdine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000831	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000829	CcSEcCtD
Delavirdine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000138	0.000827	CcSEcCtD
Delavirdine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000825	CcSEcCtD
Delavirdine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000822	CcSEcCtD
Delavirdine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000821	CcSEcCtD
Delavirdine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000137	0.000819	CcSEcCtD
Delavirdine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000816	CcSEcCtD
Delavirdine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.000814	CcSEcCtD
Delavirdine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000814	CcSEcCtD
Delavirdine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000136	0.000812	CcSEcCtD
Delavirdine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000136	0.000811	CcSEcCtD
Delavirdine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000809	CcSEcCtD
Delavirdine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000807	CcSEcCtD
Delavirdine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000807	CcSEcCtD
Delavirdine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000135	0.000806	CcSEcCtD
Delavirdine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000804	CcSEcCtD
Delavirdine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000804	CcSEcCtD
Delavirdine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000134	0.000803	CcSEcCtD
Delavirdine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000801	CcSEcCtD
Delavirdine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000801	CcSEcCtD
Delavirdine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000801	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000799	CcSEcCtD
Delavirdine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.000798	CcSEcCtD
Delavirdine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000791	CcSEcCtD
Delavirdine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000791	CcSEcCtD
Delavirdine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000785	CcSEcCtD
Delavirdine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000785	CcSEcCtD
Delavirdine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.000778	CcSEcCtD
Delavirdine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00013	0.000778	CcSEcCtD
Delavirdine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00013	0.000775	CcSEcCtD
Delavirdine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00013	0.000775	CcSEcCtD
Delavirdine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.000775	CcSEcCtD
Delavirdine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.000775	CcSEcCtD
Delavirdine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000772	CcSEcCtD
Delavirdine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000129	0.000772	CcSEcCtD
Delavirdine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.000765	CcSEcCtD
Delavirdine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.000765	CcSEcCtD
Delavirdine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000128	0.000765	CcSEcCtD
Delavirdine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000128	0.000762	CcSEcCtD
Delavirdine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000762	CcSEcCtD
Delavirdine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.000761	CcSEcCtD
Delavirdine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.00076	CcSEcCtD
Delavirdine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000127	0.000759	CcSEcCtD
Delavirdine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000127	0.000759	CcSEcCtD
Delavirdine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000757	CcSEcCtD
Delavirdine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000743	CcSEcCtD
Delavirdine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000735	CcSEcCtD
Delavirdine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000731	CcSEcCtD
Delavirdine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000731	CcSEcCtD
Delavirdine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000121	0.000722	CcSEcCtD
Delavirdine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.000722	CcSEcCtD
Delavirdine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000121	0.000721	CcSEcCtD
Delavirdine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000719	CcSEcCtD
Delavirdine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000118	0.000707	CcSEcCtD
Delavirdine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000703	CcSEcCtD
Delavirdine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000703	CcSEcCtD
Delavirdine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000693	CcSEcCtD
Delavirdine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000693	CcSEcCtD
Delavirdine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000692	CcSEcCtD
Delavirdine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000689	CcSEcCtD
Delavirdine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000683	CcSEcCtD
Delavirdine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000682	CcSEcCtD
Delavirdine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000679	CcSEcCtD
Delavirdine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.00067	CcSEcCtD
Delavirdine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000112	0.00067	CcSEcCtD
Delavirdine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000665	CcSEcCtD
Delavirdine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000664	CcSEcCtD
Delavirdine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00066	CcSEcCtD
Delavirdine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00258	CbGpPWpGaD
Delavirdine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000657	CcSEcCtD
Delavirdine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.000655	CcSEcCtD
Delavirdine—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.00256	CbGpPWpGaD
Delavirdine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.00065	CcSEcCtD
Delavirdine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000648	CcSEcCtD
Delavirdine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000648	CcSEcCtD
Delavirdine—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000108	0.00254	CbGpPWpGaD
Delavirdine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000635	CcSEcCtD
Delavirdine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000634	CcSEcCtD
Delavirdine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000633	CcSEcCtD
Delavirdine—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.00246	CbGpPWpGaD
Delavirdine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000624	CcSEcCtD
Delavirdine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000623	CcSEcCtD
Delavirdine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000623	CcSEcCtD
Delavirdine—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00244	CbGpPWpGaD
Delavirdine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00243	CbGpPWpGaD
Delavirdine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000618	CcSEcCtD
Delavirdine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000618	CcSEcCtD
Delavirdine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000617	CcSEcCtD
Delavirdine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000617	CcSEcCtD
Delavirdine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000617	CcSEcCtD
Delavirdine—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.00242	CbGpPWpGaD
Delavirdine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000614	CcSEcCtD
Delavirdine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000614	CcSEcCtD
Delavirdine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000613	CcSEcCtD
Delavirdine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000612	CcSEcCtD
Delavirdine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000612	CcSEcCtD
Delavirdine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000102	0.00061	CcSEcCtD
Delavirdine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000605	CcSEcCtD
Delavirdine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00238	CbGpPWpGaD
Delavirdine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000605	CcSEcCtD
Delavirdine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000603	CcSEcCtD
Delavirdine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00237	CbGpPWpGaD
Delavirdine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000601	CcSEcCtD
Delavirdine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.0001	0.00236	CbGpPWpGaD
Delavirdine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	9.94e-05	0.000594	CcSEcCtD
Delavirdine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	9.91e-05	0.000593	CcSEcCtD
Delavirdine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.85e-05	0.00232	CbGpPWpGaD
Delavirdine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.84e-05	0.000588	CcSEcCtD
Delavirdine—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.81e-05	0.000586	CcSEcCtD
Delavirdine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.77e-05	0.000584	CcSEcCtD
Delavirdine—Rash—Salbutamol—chronic obstructive pulmonary disease	9.76e-05	0.000583	CcSEcCtD
Delavirdine—Syncope—Prednisolone—chronic obstructive pulmonary disease	9.75e-05	0.000583	CcSEcCtD
Delavirdine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.75e-05	0.000583	CcSEcCtD
Delavirdine—Nausea—Formoterol—chronic obstructive pulmonary disease	9.73e-05	0.000582	CcSEcCtD
Delavirdine—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.73e-05	0.000582	CcSEcCtD
Delavirdine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.73e-05	0.00229	CbGpPWpGaD
Delavirdine—Headache—Salbutamol—chronic obstructive pulmonary disease	9.69e-05	0.00058	CcSEcCtD
Delavirdine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.56e-05	0.000571	CcSEcCtD
Delavirdine—Nausea—Montelukast—chronic obstructive pulmonary disease	9.54e-05	0.00057	CcSEcCtD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	9.5e-05	0.00223	CbGpPWpGaD
Delavirdine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.5e-05	0.00223	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	9.5e-05	0.00223	CbGpPWpGaD
Delavirdine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.39e-05	0.000561	CcSEcCtD
Delavirdine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	9.36e-05	0.0022	CbGpPWpGaD
Delavirdine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	9.25e-05	0.00217	CbGpPWpGaD
Delavirdine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	9.24e-05	0.000553	CcSEcCtD
Delavirdine—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.19e-05	0.00055	CcSEcCtD
Delavirdine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	9.15e-05	0.000547	CcSEcCtD
Delavirdine—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.09e-05	0.00214	CbGpPWpGaD
Delavirdine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.06e-05	0.00213	CbGpPWpGaD
Delavirdine—Hallucination—Prednisone—chronic obstructive pulmonary disease	9.03e-05	0.00054	CcSEcCtD
Delavirdine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.99e-05	0.00211	CbGpPWpGaD
Delavirdine—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.99e-05	0.00211	CbGpPWpGaD
Delavirdine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.95e-05	0.0021	CbGpPWpGaD
Delavirdine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.94e-05	0.0021	CbGpPWpGaD
Delavirdine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.88e-05	0.00209	CbGpPWpGaD
Delavirdine—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.88e-05	0.000531	CcSEcCtD
Delavirdine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.87e-05	0.00208	CbGpPWpGaD
Delavirdine—Shock—Prednisolone—chronic obstructive pulmonary disease	8.73e-05	0.000522	CcSEcCtD
Delavirdine—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.72e-05	0.00205	CbGpPWpGaD
Delavirdine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.66e-05	0.000518	CcSEcCtD
Delavirdine—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.6e-05	0.00202	CbGpPWpGaD
Delavirdine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.58e-05	0.000513	CcSEcCtD
Delavirdine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	8.34e-05	0.00196	CbGpPWpGaD
Delavirdine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.16e-05	0.00192	CbGpPWpGaD
Delavirdine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.05e-05	0.00189	CbGpPWpGaD
Delavirdine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.03e-05	0.00048	CcSEcCtD
Delavirdine—Alopecia—Prednisone—chronic obstructive pulmonary disease	8.02e-05	0.00048	CcSEcCtD
Delavirdine—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.01e-05	0.00188	CbGpPWpGaD
Delavirdine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.99e-05	0.00188	CbGpPWpGaD
Delavirdine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.97e-05	0.000476	CcSEcCtD
Delavirdine—Erythema—Prednisone—chronic obstructive pulmonary disease	7.9e-05	0.000472	CcSEcCtD
Delavirdine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	7.9e-05	0.000472	CcSEcCtD
Delavirdine—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.9e-05	0.00186	CbGpPWpGaD
Delavirdine—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.87e-05	0.00185	CbGpPWpGaD
Delavirdine—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.78e-05	0.00183	CbGpPWpGaD
Delavirdine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.68e-05	0.0018	CbGpPWpGaD
Delavirdine—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.59e-05	0.00178	CbGpPWpGaD
Delavirdine—Pain—Prednisolone—chronic obstructive pulmonary disease	7.59e-05	0.000454	CcSEcCtD
Delavirdine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.58e-05	0.00178	CbGpPWpGaD
Delavirdine—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.55e-05	0.00178	CbGpPWpGaD
Delavirdine—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.49e-05	0.00176	CbGpPWpGaD
Delavirdine—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.45e-05	0.00175	CbGpPWpGaD
Delavirdine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.45e-05	0.000445	CcSEcCtD
Delavirdine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.35e-05	0.00173	CbGpPWpGaD
Delavirdine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.33e-05	0.000438	CcSEcCtD
Delavirdine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.33e-05	0.00172	CbGpPWpGaD
Delavirdine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.31e-05	0.000437	CcSEcCtD
Delavirdine—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.3e-05	0.000437	CcSEcCtD
Delavirdine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.28e-05	0.00171	CbGpPWpGaD
Delavirdine—Agitation—Prednisone—chronic obstructive pulmonary disease	7.26e-05	0.000434	CcSEcCtD
Delavirdine—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.22e-05	0.000432	CcSEcCtD
Delavirdine—Malaise—Prednisone—chronic obstructive pulmonary disease	7.13e-05	0.000426	CcSEcCtD
Delavirdine—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.1e-05	0.000424	CcSEcCtD
Delavirdine—Syncope—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.000424	CcSEcCtD
Delavirdine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.05e-05	0.000422	CcSEcCtD
Delavirdine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.03e-05	0.00165	CbGpPWpGaD
Delavirdine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.95e-05	0.00163	CbGpPWpGaD
Delavirdine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.95e-05	0.000415	CcSEcCtD
Delavirdine—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.000408	CcSEcCtD
Delavirdine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.73e-05	0.000402	CcSEcCtD
Delavirdine—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.73e-05	0.000402	CcSEcCtD
Delavirdine—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000401	CcSEcCtD
Delavirdine—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.65e-05	0.000397	CcSEcCtD
Delavirdine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.61e-05	0.00155	CbGpPWpGaD
Delavirdine—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.54e-05	0.00154	CbGpPWpGaD
Delavirdine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.54e-05	0.000391	CcSEcCtD
Delavirdine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.49e-05	0.00152	CbGpPWpGaD
Delavirdine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.46e-05	0.00152	CbGpPWpGaD
Delavirdine—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.45e-05	0.00152	CbGpPWpGaD
Delavirdine—Oedema—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.000386	CcSEcCtD
Delavirdine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.41e-05	0.00151	CbGpPWpGaD
Delavirdine—Infection—Prednisone—chronic obstructive pulmonary disease	6.41e-05	0.000383	CcSEcCtD
Delavirdine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.39e-05	0.0015	CbGpPWpGaD
Delavirdine—Shock—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.000379	CcSEcCtD
Delavirdine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.33e-05	0.00149	CbGpPWpGaD
Delavirdine—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.3e-05	0.00148	CbGpPWpGaD
Delavirdine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000376	CcSEcCtD
Delavirdine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.26e-05	0.000375	CcSEcCtD
Delavirdine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.24e-05	0.000373	CcSEcCtD
Delavirdine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.22e-05	0.00146	CbGpPWpGaD
Delavirdine—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.21e-05	0.00146	CbGpPWpGaD
Delavirdine—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.15e-05	0.000368	CcSEcCtD
Delavirdine—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	6.11e-05	0.00144	CbGpPWpGaD
Delavirdine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.96e-05	0.0014	CbGpPWpGaD
Delavirdine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.93e-05	0.00139	CbGpPWpGaD
Delavirdine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000351	CcSEcCtD
Delavirdine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.87e-05	0.000351	CcSEcCtD
Delavirdine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.85e-05	0.00137	CbGpPWpGaD
Delavirdine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.84e-05	0.00137	CbGpPWpGaD
Delavirdine—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.83e-05	0.000349	CcSEcCtD
Delavirdine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.79e-05	0.000346	CcSEcCtD
Delavirdine—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.79e-05	0.00136	CbGpPWpGaD
Delavirdine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.76e-05	0.00135	CbGpPWpGaD
Delavirdine—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.71e-05	0.00134	CbGpPWpGaD
Delavirdine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.68e-05	0.000339	CcSEcCtD
Delavirdine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.61e-05	0.000335	CcSEcCtD
Delavirdine—Rash—Prednisolone—chronic obstructive pulmonary disease	5.6e-05	0.000335	CcSEcCtD
Delavirdine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.59e-05	0.000334	CcSEcCtD
Delavirdine—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.56e-05	0.000332	CcSEcCtD
Delavirdine—Headache—Prednisolone—chronic obstructive pulmonary disease	5.56e-05	0.000332	CcSEcCtD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.53e-05	0.0013	CbGpPWpGaD
Delavirdine—Constipation—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.00033	CcSEcCtD
Delavirdine—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.49e-05	0.00129	CbGpPWpGaD
Delavirdine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.48e-05	0.00129	CbGpPWpGaD
Delavirdine—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.46e-05	0.00128	CbGpPWpGaD
Delavirdine—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.41e-05	0.00127	CbGpPWpGaD
Delavirdine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.41e-05	0.00127	CbGpPWpGaD
Delavirdine—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.38e-05	0.00126	CbGpPWpGaD
Delavirdine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.37e-05	0.00126	CbGpPWpGaD
Delavirdine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.33e-05	0.00125	CbGpPWpGaD
Delavirdine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.31e-05	0.000318	CcSEcCtD
Delavirdine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.3e-05	0.00125	CbGpPWpGaD
Delavirdine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.27e-05	0.000315	CcSEcCtD
Delavirdine—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.27e-05	0.000315	CcSEcCtD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.25e-05	0.00123	CbGpPWpGaD
Delavirdine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.25e-05	0.00123	CbGpPWpGaD
Delavirdine—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.12e-05	0.000306	CcSEcCtD
Delavirdine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.1e-05	0.000305	CcSEcCtD
Delavirdine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.1e-05	0.000305	CcSEcCtD
Delavirdine—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.02e-05	0.00118	CbGpPWpGaD
Delavirdine—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.95e-05	0.00116	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.94e-05	0.00116	CbGpPWpGaD
Delavirdine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.87e-05	0.00114	CbGpPWpGaD
Delavirdine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.8e-05	0.00113	CbGpPWpGaD
Delavirdine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.8e-05	0.00113	CbGpPWpGaD
Delavirdine—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.75e-05	0.00112	CbGpPWpGaD
Delavirdine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.75e-05	0.000284	CcSEcCtD
Delavirdine—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.69e-05	0.0011	CbGpPWpGaD
Delavirdine—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.63e-05	0.000277	CcSEcCtD
Delavirdine—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.56e-05	0.000273	CcSEcCtD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.5e-05	0.00106	CbGpPWpGaD
Delavirdine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.48e-05	0.00105	CbGpPWpGaD
Delavirdine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.48e-05	0.00105	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.45e-05	0.00105	CbGpPWpGaD
Delavirdine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.44e-05	0.00104	CbGpPWpGaD
Delavirdine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.42e-05	0.00104	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	4.42e-05	0.00104	CbGpPWpGaD
Delavirdine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.42e-05	0.00104	CbGpPWpGaD
Delavirdine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.000264	CcSEcCtD
Delavirdine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.38e-05	0.00103	CbGpPWpGaD
Delavirdine—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.27e-05	0.000255	CcSEcCtD
Delavirdine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.24e-05	0.000997	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.23e-05	0.000993	CbGpPWpGaD
Delavirdine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.19e-05	0.000984	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.18e-05	0.000982	CbGpPWpGaD
Delavirdine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.12e-05	0.000968	CbGpPWpGaD
Delavirdine—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.1e-05	0.000245	CcSEcCtD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.08e-05	0.00096	CbGpPWpGaD
Delavirdine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.08e-05	0.000959	CbGpPWpGaD
Delavirdine—Rash—Prednisone—chronic obstructive pulmonary disease	4.07e-05	0.000243	CcSEcCtD
Delavirdine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.06e-05	0.000243	CcSEcCtD
Delavirdine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.06e-05	0.000954	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.05e-05	0.000951	CbGpPWpGaD
Delavirdine—Headache—Prednisone—chronic obstructive pulmonary disease	4.04e-05	0.000242	CcSEcCtD
Delavirdine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.03e-05	0.000946	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4e-05	0.000941	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4e-05	0.000941	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	3.94e-05	0.000925	CbGpPWpGaD
Delavirdine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.9e-05	0.000917	CbGpPWpGaD
Delavirdine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.87e-05	0.000909	CbGpPWpGaD
Delavirdine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.85e-05	0.000905	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.85e-05	0.000905	CbGpPWpGaD
Delavirdine—Nausea—Prednisone—chronic obstructive pulmonary disease	3.83e-05	0.000229	CcSEcCtD
Delavirdine—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	3.82e-05	0.000899	CbGpPWpGaD
Delavirdine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.82e-05	0.000897	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.81e-05	0.000896	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.81e-05	0.000896	CbGpPWpGaD
Delavirdine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.8e-05	0.000892	CbGpPWpGaD
Delavirdine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.74e-05	0.00088	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.66e-05	0.00086	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.51e-05	0.000825	CbGpPWpGaD
Delavirdine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.49e-05	0.00082	CbGpPWpGaD
Delavirdine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.46e-05	0.000814	CbGpPWpGaD
Delavirdine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.44e-05	0.000808	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.41e-05	0.000802	CbGpPWpGaD
Delavirdine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.31e-05	0.000777	CbGpPWpGaD
Delavirdine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.26e-05	0.000766	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.14e-05	0.000738	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.11e-05	0.000732	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.93e-05	0.000688	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.93e-05	0.000687	CbGpPWpGaD
Delavirdine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.89e-05	0.000679	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.85e-05	0.000669	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.73e-05	0.000641	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.69e-05	0.000633	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.66e-05	0.000625	CbGpPWpGaD
Delavirdine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.65e-05	0.000624	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.65e-05	0.000622	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.55e-05	0.0006	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.53e-05	0.000595	CbGpPWpGaD
Delavirdine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.52e-05	0.000591	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.51e-05	0.000591	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.46e-05	0.000579	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.43e-05	0.000572	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.29e-05	0.000538	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.26e-05	0.000531	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.24e-05	0.000527	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.22e-05	0.000522	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.2e-05	0.000517	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.15e-05	0.000505	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.13e-05	0.0005	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.08e-05	0.000489	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.06e-05	0.000485	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.05e-05	0.000482	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.05e-05	0.000481	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.05e-05	0.000481	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.02e-05	0.000476	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.01e-05	0.000471	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.94e-05	0.000456	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.9e-05	0.000446	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.88e-05	0.000442	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.86e-05	0.000438	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.83e-05	0.000429	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.79e-05	0.00042	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.76e-05	0.000414	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.71e-05	0.000403	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	0.000383	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.59e-05	0.000375	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.55e-05	0.000365	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.54e-05	0.000361	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.49e-05	0.00035	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.49e-05	0.000349	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.47e-05	0.000345	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.4e-05	0.00033	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.37e-05	0.000322	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.36e-05	0.00032	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.35e-05	0.000316	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.33e-05	0.000313	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.32e-05	0.000311	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.3e-05	0.000305	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	0.000304	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.27e-05	0.000298	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.24e-05	0.000292	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.23e-05	0.000289	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.21e-05	0.000285	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.2e-05	0.000282	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.19e-05	0.000279	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.12e-05	0.000263	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.11e-05	0.00026	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.11e-05	0.00026	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.1e-05	0.000258	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.09e-05	0.000257	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.08e-05	0.000255	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000255	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.08e-05	0.000253	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.06e-05	0.00025	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.01e-05	0.000237	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.99e-06	0.000235	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.97e-06	0.000234	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.9e-06	0.000233	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	9.88e-06	0.000232	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.39e-06	0.000221	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.36e-06	0.00022	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.33e-06	0.000219	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.26e-06	0.000218	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.2e-06	0.000216	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.19e-06	0.000216	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.11e-06	0.000214	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	8.83e-06	0.000207	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.63e-06	0.000203	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.58e-06	0.000202	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.45e-06	0.000199	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	8.44e-06	0.000198	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.33e-06	0.000196	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.22e-06	0.000193	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.13e-06	0.000191	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.66e-06	0.00018	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.66e-06	0.00018	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.6e-06	0.000179	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.56e-06	0.000178	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.49e-06	0.000176	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.26e-06	0.000171	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.23e-06	0.00017	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.14e-06	0.000168	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.04e-06	0.000165	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.98e-06	0.000164	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.68e-06	0.000157	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.62e-06	0.000156	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.52e-06	0.000153	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.49e-06	0.000153	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.4e-06	0.00015	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	6.38e-06	0.00015	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	6.1e-06	0.000143	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.01e-06	0.000141	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.97e-06	0.00014	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.65e-06	0.000133	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	5.53e-06	0.00013	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	5.29e-06	0.000124	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.01e-06	0.000118	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.94e-06	0.000116	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.93e-06	0.000116	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.72e-06	0.000111	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.6e-06	0.000108	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.54e-06	0.000107	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.5e-06	0.000106	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.36e-06	0.000103	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.34e-06	0.000102	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.3e-06	0.000101	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.84e-06	9.03e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.68e-06	8.64e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.97e-06	6.97e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.84e-06	6.67e-05	CbGpPWpGaD
